Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PECAM-1/CD31 is a pivotal regulator at the interface between blood components and vessel walls with diverse roles spanning from maintaining vascular homeostasis to modulating immune responses. It is expressed on endothelial cells, platelets, and leukocytes and is involved in adhesion, signaling, vascular biology, leukocyte trafficking, platelet function, and angiogenesis. Its ITIM motifs allow it to function as an inhibitory receptor. It is being explored as a therapeutic target for diseases involving abnormal inflammation or thrombosis and for targeted drug delivery.
Modulation of PECAM-mediated signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet endothelial cell adhesion molecule 1 (PECAM-1).